ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹467 Cr | ₹484 Cr | ₹392 Cr | ₹373 Cr | ₹367 Cr |
What is the latest Total Current Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹467 Cr |
Mar2023 | ₹484 Cr |
Mar2022 | ₹392 Cr |
Mar2021 | ₹373 Cr |
Mar2020 | ₹367 Cr |
How is Total Current Liabilities of ASTRAZENECA PHARMA INDIA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹467 Cr | -3.56 | |
Mar2023 | ₹484 Cr | 23.48 | |
Mar2022 | ₹392 Cr | 5.05 | |
Mar2021 | ₹373 Cr | 1.72 | |
Mar2020 | ₹367 Cr | - |
Compare Total Current Liabilities of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹17,683.0 Cr | 2.5% | 7.7% | 7.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,050.0 Cr | 2% | -0.9% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,208.0 Cr | -1.6% | -0.4% | 57.3% | Stock Analytics | |
CIPLA | ₹117,197.0 Cr | -0.3% | -2.5% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,586.0 Cr | -0.5% | -3.3% | 14% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,496.4 Cr | -1% | 0.6% | 39.1% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | 2.5% |
7.7% |
7.5% |
SENSEX | -0.7% |
-2.6% |
7.5% |
You may also like the below Video Courses